<PAGE> 1
-------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 10-Q/A
/X/ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1995
/ / Transition report pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934.
COMMISSION FILE NUMBER 0-16617
ALTERA CORPORATION
(Exact name of registrant as specified in its charter)
CALIFORNIA 77-0016691
(State or other jurisdiction (I.R.S. Employer
of incorporation or organization) Identification Number)
2610 ORCHARD PARKWAY
SAN JOSE, CALIFORNIA 95134
(Address of Principal Executive Offices)
Telephone: (408) 894-7000
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such period that the registrant was required to
file such reports), and (2) has been subject to such filing requirements for the
past 90 days.
Yes X No
--- ---
AS OF JUNE 30, 1995, THERE WERE 43,332,407 SHARES OF COMMON STOCK,
NO PAR VALUE, OUTSTANDING.
-------------------------------------------------------------------------------
Page 1 of 3
<PAGE> 2
ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K
(a) Exhibits
3.2 Certificate of Amendment of Articles of
Incorporation of the Company filed on May 10, 1995.
4.2 Indenture agreement dated as of June 15, 1995 by and
between registrant and The First National Bank of
Boston, as trustee.
4.3 Form of Convertible Subordinated Note due 2002.
10.39 Wafer Supply Agreement dated June 26, 1995 between
registrant and Taiwan Semiconductor Manufacturing
Co., Ltd.*
10.40 Option Agreement dated June 26, 1995 between
registrant and Taiwan Semiconductor Manufacturing
Co., Ltd.*
11.1 Computation of earnings per share (see Note 3 to
Financial Information in Part 1 of Form 10-Q).
27. Financial Data Schedule.
*Confidential treatment requested pursuant to a request for
confidential treatment filed with the Commission on August 15,
1995. The portions of the exhibit for which confidential
treatment has been requested have been omitted from the
exhibit and are marked with asterisks. The omitted information
has been filed separately with the Commission as part of the
confidential treatment requested.
(b) Reports on Form 8-K
On June 5, 1995, the registrant filed a report on
Form 8-K reporting that the registrant had announced its
intention, subject to market and other conditions, to raise
$150 million in a private placement of convertible
subordinated notes to institutional buyers, and up to $172.5
million in an over-allotment option to be granted to the
initial purchasers were exercised in full.
On June 20, 1995, the registrant filed a report on
Form 8-K reporting that the registrant had announced the
purchase of approximately 25 acres of undeveloped land for
approximately $20,000,000, to be used for development of a new
corporate facility.
On June 22, 1995, the registrant filed a report on
Form 8-K reporting that the registrant had announced that it
increased the size of its private placement of 5-3/4%
convertible subordinated notes due 2002 from $150 million to
$200 million ($230 million, including the full over-allotment
option), and that the transaction has closed June 21, 1995.
Page 2 of 3
<PAGE> 3
SIGNATURES
Pursuant to the requirements of Securities Exchange Act of 1934, the registrant
has duly caused this amendment to the report on Form 10-Q to be signed on its
behalf by the undersigned thereunto duly authorized.
Date: September 18, 1995
ALTERA CORPORATION
By: /S/NATHAN M. SARKISIAN
-----------------------------------
Nathan M.Sarkisian
Vice President, Finance
and Chief Financial Officer
Page 3 of 3
